KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Current Assets: 2009-2025

Historic Current Assets for Neogenomics (NEO) over the last 16 years, with Sep 2025 value amounting to $382.5 million.

  • Neogenomics' Current Assets fell 35.20% to $382.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $382.5 million, marking a year-over-year decrease of 35.20%. This contributed to the annual value of $596.0 million for FY2024, which is 0.13% down from last year.
  • Latest data reveals that Neogenomics reported Current Assets of $382.5 million as of Q3 2025, which was down 2.57% from $392.6 million recorded in Q2 2025.
  • Neogenomics' Current Assets' 5-year high stood at $942.7 million during Q1 2021, with a 5-year trough of $382.5 million in Q3 2025.
  • For the 3-year period, Neogenomics' Current Assets averaged around $549.7 million, with its median value being $584.7 million (2023).
  • Per our database at Business Quant, Neogenomics' Current Assets surged by 337.58% in 2021 and then plummeted by 35.20% in 2025.
  • Quarterly analysis of 5 years shows Neogenomics' Current Assets stood at $681.5 million in 2021, then declined by 11.18% to $605.3 million in 2022, then decreased by 1.40% to $596.8 million in 2023, then fell by 0.13% to $596.0 million in 2024, then crashed by 35.20% to $382.5 million in 2025.
  • Its last three reported values are $382.5 million in Q3 2025, $392.6 million for Q2 2025, and $573.9 million during Q1 2025.